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PCLINICAL RESEARCH Prognosticators in Acute Infarction
Long-Term Prognostic Value of ST-Segment
Resolution in Patients Treated With Fibrinolysis
or Primary Percutaneous Coronary Intervention
Results From the DANAMI-2 (DANish trial in Acute Myocardial Infarction-2)
Maria Sejersten, MD,* Nana Valeur, MD, PHD,* Peer Grande, MD, DMSC,*
Torsten Toftegaard Nielsen, MD, DMSC,† Peter Clemmensen, MD, DMSC,*
for the DANAMI-2 Investigators
Copenhagen and Aarhus, Denmark
Objectives The purpose of this study was to determine the prognostic value of ST-segment resolution after primary percuta-
neous coronary intervention (pPCI) versus fibrinolysis.
Background Resolution of the ST-segment has been used as a surrogate end point in trials evaluating reperfusion in acute
myocardial infarction; however, its prognostic significance may be limited to patients treated with fibrinolysis.
Methods In the DANAMI-2 (DANish trial in Acute Myocardial Infarction-2) substudy, including 1,421 patients, the ST-
segment elevation at baseline, pre-intervention, 90 min, and 4 h was assessed. The ST-segment resolution was
grouped as follows: 1) complete 70%; 2) partial 30% to 70%; and 3) no resolution 30%. End points were
30-day and long-term mortality and reinfarction.
Results The ST-segment resolution at 90 min was more pronounced after pPCI (median 60% vs. 45%, p  0.0001), and
a catch-up phenomenon was observed at 4 h. In the fibrinolysis group, 30-day and long-term mortality rates
were significantly higher among patients without ST-segment resolution, whereas reinfarction rates were higher
with complete ST-segment resolution. The ST-segment resolution was not associated with the 2 end points in the
pPCI group. By multivariate analysis, ST-segment resolution at 4 h was an independent predictor of lower mor-
tality, but higher reinfarction rates among patients receiving fibrinolytic therapy.
Conclusions The ST-segment resolution at 90 min was more complete after pPCI, suggesting better epicardial and microvascular
reperfusion, whereas no difference between treatment strategies was seen at 4 h. The ST-segment resolution at 4 h
correlated with decreased mortality, but increased reinfarction rates among patients receiving fibrinolytic therapy,
whereas no association was seen for patients receiving pPCI. Consequently, 4-h ST-segment resolution remains
an important prognosticator after fibrinolysis, but may be overemphasized as a surrogate end point after pPCI.
(J Am Coll Cardiol 2009;54:1763–9) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.03.084a
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tack of ST-segment resolution despite attainment of TIMI
Thrombolysis In Myocardial Infarction) flow grade 3 in the
picardial coronary artery is associated with an increased
ortality risk, and ST-segment resolution is considered a
arker for microvascular perfusion (1). Prior studies have
hown that TIMI flow grade 3 is obtained in more patients
fter primary percutaneous coronary intervention (pPCI) than
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ode of reperfusion and ST-segment resolution is uncertain.
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ersus fibrinolysis, we hypothesized that early ST-segment
esolution is more complete with pPCI, and the prognostic
alue of ST-segment resolution differs with the mode of
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ST-Segment Resolution and Outcome November 3, 2009:1763–9Methods
Patient population. The DAN-
AMI-2 (DANish trial in Acute
Myocardial Infarction-2) ran-
domly assigned 1,572 patients
with ST-segment elevation myo-
cardial infarction (STEMI) to ei-
ther pPCI or fibrinolysis with
front-loaded tissue plasminogen
activator (2). The present substudy
was conducted in patients with an
available randomization 12-lead
electrocardiogram (ECG) with
complete ST-segment measure-
ments. The DANAMI-2 study
omplied with the Declaration of Helsinki, and the local
thics Committee and Danish Data Protection Agency ap-
roved data collection.
lectrocardiographic data. A standard 12-lead ECG was
erformed in all patients at randomization (baseline ECG).
dditional ECGs were obtained immediately before start of
eperfusion treatment, and as timely, as clinically feasible at
0 min and 4 h after initiation of reperfusion treatment. The
CGs were analyzed at a centralized core laboratory blinded
o all patient data. The ST-segment deviation was measured
anually in the J-point to the nearest 0.5 mm in all leads
xcept aVR. The sum of ST-segment elevation (ST1) in
ll leads was determined for the individual ECG, and
T-segment resolution was assessed by the reduction in
ST1 between the baseline ECG and the following ECG
s the percentage of baseline ST1. Patients were divided
nto 3 groups according to the amount of ST-segment
Abbreviations
and Acronyms
ECG  electrocardiogram
IQR  interquartile range
PCI  percutaneous
coronary intervention
pPCI  primary
percutaneous coronary
intervention
STEMI  ST-segment
elevation myocardial
infarction
ST1  sum of ST-
segment elevation
Demography According to Reperfusion TherapyTable 1 Demography According to Reperfus
Age, yrs
Males
Family history of coronary heart disease
Hypertension
Dyslipidemia
Diabetes mellitus
Current smoker
Peripheral arterial disease
History of stroke
History of MI
History of congestive heart failure
Time from randomization to fibrinolysis injection/first balloo
Systolic blood pressure at randomization, mm Hg
Baseline ST-segment elevation, mm
Infarct location
Anterior MI
Inferior/posterior MI
Other MI location
Values aremedian (interquartile range) or n (%). Hypertension, dyslipide
diagnosed before randomization and received treatment (diabetes mellitus: d
MI  myocardial infarction; pPCI  primary percutaneous coronary interveesolution: 1) complete ST-segment resolution (70%);
) partial ST-segment resolution (30% to70%); and 3) no
esolution (30%) (3).
nd points. The end points were 30-day and long-term
ortality from any cause or clinical reinfarction (2). Median
ollow-up was 4.2 years for mortality and 3.0 years for
einfarction. No patients were lost to follow-up.
tatistics. Baseline dichotomous variables were compared
sing the chi-square test and presented as percentages, and
ontinuous variables were compared using a rank-sum test
nd presented as median with interquartile range (IQR).
he rate of events in the 3 different ST-segment resolution
ategories at 90 min and 4 h were analyzed using the trend
est. Kaplan-Meier curves were compared using log-rank
tatistics. Univariate analysis was performed for all baseline
ariables, and significant variables were included in a mul-
ivariable backward selection model excluding all variables
ith a p value 0.05. The Cox proportional hazard model
as used to determine predictors of outcome. The ST-
esolution was entered into the Cox model as a continuous
ariable and hazard ratio given per ST-segment resolution
ncrease of 1%. Interactions were assessed by entering the
nteraction term into the Cox model. A p value (2-sided)
0.05 was considered significant. The SAS software, ver-
ion 8.0 (SAS Institute, Cary, North Carolina) was used.
esults
emographics for the 1,421 included patients with a
aseline ECG are presented in Table 1. The ECGs re-
orded at pre-intervention, at 90 min, and at 4 h were
vailable for 880, 1,233, and 1,208 patients, respectively.
herapy
Fibrinolysis
(n  711)
pPCI
(n  710) p Value
63 (54–73) 63 (54–72) 0.6
524 (75) 517 (73) 0.7
273 (41) 250 (36) 0.1
148 (21) 140 (20) 0.6
44 (6) 43 (6) 0.9
48 (7) 53 (8) 0.6
410 (59) 415 (59) 0.8
30 (4) 30 (4) 1.0
13 (2) 5 (1) 0.06
79 (11) 80 (11) 0.9
37 (5) 22 (3) 0.05
20 (15–30) 69 (52–89) 0.0001
135 (115–150) 137 (120–152) 0.3
10 (6–14.5) 10 (7–15) 0.3
318 (45) 339 (48)
246 (34) 239 (34) 0.5
147 (21) 132 (18)
d diabetesmellitus were considered present when a patient had beenion T
n, min
mia, an
iet, sulfonylurea, or insulin).
ntion.
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November 3, 2009:1763–9 ST-Segment Resolution and OutcomeT-segment resolution and treatment groups. Figure 1
emonstrates median percent ST-segment resolution over
ime in the 2 treatment groups. Before the reperfusion
ttempt, more ST-segment resolution occurred in patients
andomly assigned to pPCI (12%, IQR 0% to 31%, vs. 6%,
QR 0% to 47%; p  0.004). Pronounced normalization of
he ST-segment was observed in both groups at 90 min, but
ignificantly more after pPCI (60%, IQR 33% to 82%, vs.
5%, IQR 13% to 71%; p  0.0001). This difference had
aded at 4 h (65%, IQR 40% to 80%, vs. 63%, IQR 35% to
5%; p  0.2).
T-segment resolution and outcome. Patient demo-
raphics according to ST-segment resolution at 4 h are
isted in Table 2. Patients without ST-segment resolution
ended to have the highest mortality rate regardless of
reatment strategy; however, this difference only reached
tatistical significance in the fibrinolysis group (Table 3, Fig.
). By multivariable analysis, age, diabetes mellitus, conges-
ive heart failure, and ST-segment resolution at 4 h were
ound to be strong predictors of long-term mortality in all
atients (Table 4). A difference in 1% ST-segment resolu-
ion increased the mortality risk by 8%. When dividing
atients according to treatment group, 4-h ST-segment
esolution and time-to-treatment were only independent
redictors of mortality in the fibrinolysis group. However,
o interaction was found between ST-segment resolution
nd treatment strategy regarding mortality (p  0.4).
In the fibrinolysis group, reinfarction rates were signifi-
antly higher among patients with complete ST-segment
Figure 1 ST-Segment Resolution
Resolution of ST-segment elevation according to time after the baseline electrocar
The red line with squares indicates percutaneous coronary intervention (PCI); theesolution, but there was no association between reinfarc- pion and ST-segment resolution for patients receiving pPCI
Table 5). Multivariable analysis of all patients showed that
ge, diabetes, heart failure, and time to treatment were
ndependent predictors of reinfarction (Table 4). In the
brinolysis group, the risk of reinfarction increased 1% with
ach additional 1% of ST-segment resolution, whereas in
he pPCI group, ST-segment resolution did not influence
einfarction rate. There was a significant interaction be-
ween ST-segment resolution and treatment strategy re-
arding reinfarction (p  0.01).
iscussion
his study showed that median percent ST-segment reso-
ution at 90 min after reperfusion therapy is more complete
ith pPCI than with fibrinolysis. However, a catch-up
henomenon occurred at 4 h, resulting in similar levels of
T-segment resolution. Interestingly, ST-segment resolu-
ion was only predictive of mortality after fibrinolysis and
ot after pPCI. Additionally, complete ST-segment reso-
ution was predictive of increased reinfarction among pa-
ients receiving fibrinolysis.
The median interval between randomization and initia-
ion of reperfusion therapy was 49 min longer with pPCI
han with fibrinolysis, inherent to the transportation delay
2). However, time from randomization to artery patency
as still similar in the 2 treatment arms because needle to
eperfusion time is approximately 45 min with fibrinolysis
4) and momentarily with pPCI. During the time delay,
m (ECG).
ne with circles indicates fibrinolysis.diogra
blue liPCI patients obtained more ST-segment resolution, which
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ST-Segment Resolution and Outcome November 3, 2009:1763–9ould be explained by either spontaneous regression or likely
nduced by aspirin and heparin intake at the referral hospital
efore transfer. On the contrary, patients randomly allo-
ated to fibrinolytic therapy were treated with aspirin and
eparin immediately before administration of fibrinolysis.
his timing difference could favor the increased ST-
egment resolution seen in the pPCI group at 90 min.
Our results are supported by an earlier study reporting a
ignificant difference in 2-h ST-segment resolution with pPCI
ersus fibrinolysis (5). The finding of more patients who were
ale, and had diabetes, prior myocardial infarction, and
nterior myocardial infarction in the group of patients without
T-segment resolution is consistent with earlier findings (3), in
hich patients without ST-segment resolution tended to have
he worst risk profile at baseline. It is noteworthy that these
igh-risk patients had the least amount of ST-segment eleva-
ion at baseline. That may be caused by a difference in etiology,
ith these patients tending to have general arthrosclerosis with
ollaterals and a smaller culprit vessel than patients with
omplete ST-segment resolution, who may have a large epi-
ardial artery with acute occlusion.
Dividing ST-segment resolution into 3 groups is a
emographics and Hospital Findings According to Degree of ST-SeTable 2 Demographics and Hospital Findings According to Deg
No Re
(<
(n 
Age, yrs 61.5 (
Males 199 (
Family history of coronary heart disease 97 (
Hypertension 50 (
Dyslipidemia 18 (
Diabetes mellitus 27 (
Current smoker 132 (
Peripheral arterial disease 13 (
History of MI 40 (
History of congestive heart failure 13 (
Time from randomization to fibrinolysis injection/first balloon, min 35 (
Systolic blood pressure at randomization, mm Hg 140 (
Baseline ST-segment elevation, mm 8.0 (
Infarct location
Anterior MI 127 (
Inferior/posterior MI 59 (
Other MI location 62 (
Maximum CK-MB 88 (
Discharge LVEF 50 (
Cardiogenic shock 16 (
Complete revascularization, TIMI flow grade 3, and stenosis 50%* 43 (
Residual stenosis in IRA, 30%* 46 (
No vessel disease* 18 (
1-vessel disease 29 (
2-vessel disease 29 (
3-vessel disease 33 (
TIMI flow grade* 3 (
alues aremedian (interquartile range) or n (%). Hypertension, dyslipidemia, and diabetesmellitus w
diabetes mellitus: diet, sulfonylurea, or insulin). *Data available for patients undergoing coronary
CK-MB  creatine kinase isoenzyme myocardial band; IRA  infarct-related artery; LVEF  leftrequently used method for determining the relationship fietween treatment and mortality (3,6). Corresponding with
ur results, van’t Hof et al. (6) found that 51% had complete
T-segment resolution 1 h after pPCI; however, we could
ot show a significant association with mortality. One
xplanation might be the use of stents in 93% of patients in
he present study versus none in the study by van’t Hof et al.
6). The placement of stents with high pressure can induce
istal embolization, which could influence ST-segment
esolution, but not mortality.
Traditionally, ST-segment resolution is determined 90 to
80 min after the start of fibrinolysis (1,7), whereas the
ptimal timing for determining ST-segment resolution
receding pPCI is uncertain (8) and may be at a much
arlier time, given the immediate artery patency with pPCI.
hat may explain why we, in this study, with the earliest
vailable post-procedure ECG recorded after 90 min, did
ot detect a relationship between ST-segment resolution
nd outcome in the pPCI group, while both 90-min and
-h ECG predicted outcome after fibrinolysis. Conse-
uently, both 90-min and 4-h ECG remain an important
redictor in fibrinolysis, whereas early continuous ECG
onitoring after pPCI may be necessary to rely on the
t Resolution at 4 Hoursf ST-Segment Resolution at 4 Hours
on
)
Partial Resolution
(30%–70%)
(n  473)
Complete Resolution
(>70%)
(n  487) p Value
) 62.0 (52–71) 63 (55–72) 0.33
359 (76) 328 (67) 0.0003
156 (35) 196 (41) 0.09
90 (19) 107 (22) 0.53
26 (6) 33 (7) 0.60
35 (7) 25 (5) 0.017
272 (58) 302 (63) 0.05
17 (4) 21 (4) 0.58
58 (12) 38 (8) 0.0023
17 (4) 18 (4) 0.51
) 42 (20–71) 41 (20–72) 0.75
55) 138 (118–153) 135 (116–150) 0.42
10.5 (7.5–15) 11.5 (8–16.5) 0.001
248 (53) 192 (39) 0.0001
139 (29) 208 (43)
86 (18) 87 (18)
6) 144.5 (77–244) 136 (67–234) 0.0001
) 50 (40–60) 50 (45–60) 0.01
23 (5) 17 (4) 0.19
134 (59) 126 (54) 0.50
146 (67) 150 (68) 0.72
5 (2) 1 (0) 0.0001
81 (35) 63 (26)
74 (32) 96 (40)
73 (31) 81 (34)
3 (3–3) 3 (3–3) 0.66
sidered present when a patient had been diagnosed before randomization and received treatment
ntion.
lar ejection fraction; TIMI Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.gmenree o
soluti
30%)
248
53–73
80)
40)
20)
7)
11)
53)
5)
16)
5)
20–68
120–1
5–11)
51)
24)
25)
20–15
43–60
6)
53)
63)
17)
27)
27)
30)
3–3)
ere conndings of future trials (8).
a
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November 3, 2009:1763–9 ST-Segment Resolution and OutcomeOur finding of complete ST-segment resolution being
ssociated with an increased rate of reinfarction in patients
reated with fibrinolysis is new. An explanation may be that
30-Day and Long-Term Mortality According to DResolution at 90 Min and 4 Hours After InitiatioTable 3 30-Day and Long-Te m Mortality AcResolution at 90 Min and 4 Hours A
No Resolution
(<30%)
ST-segment resolution, 90 min
All (n 1,233) 365 (30%)
pPCI (n 602) 129 (21%)
Fibrinolysis (n (631) 236 (37%)
30-day mortality
pPCI 7 (5%)
Fibrinolysis 22 (9%)
4.2-yr mortality
pPCI 21 (16%)
Fibrinolysis 49 (21%)
ST-segment resolution, 4 h (%)
All (n 1,208) 248 (21%)
pPCI (n 608) 112 (18%)
Fibrinolysis (n 600) 126 (22%)
30-day mortality
pPCI 5 (4%)
Fibrinolysis 14 (10%)
4.2-yr mortality
pPCI 22 (20%)
Fibrinolysis 32 (24%)
Abbreviation as in Table 1.
Figure 2 Mortality Rates
Kaplan-Meier curves illustrating mortality rates in the 2 treatment groups. The gre
blue line indicates partial resolution, and the red line indicates no resolution. PCIatients with complete ST-segment resolution are experi-
ncing a large acute occlusion. When the occlusion is
emoved by fibrinolysis, it leaves a vulnerable plaque prone
of ST-SegmentReperfusion Therapyng to Degree of ST-Segment
Initiation of Reperfusion Therapy
al Resolution
0%–70%)
Complete Resolution
(>70%) p Value
61 (37%) 407 (33%)
33 (39%) 240 (40%)
28 (36%) 167 (27%)
15 (6%) 5 (2%) 0.07
11 (5%) 5 (3%) 0.007
40 (17%) 28 (12%) 0.2
33 (14%) 22 (13%) 0.03
73 (39%) 487 (40%)
46 (41%) 250 (41%)
27 (28%) 237 (40%)
14 (6%) 11 (4%) 0.8
13 (6%) 5 (2%) 0.0007
38 (15%) 37 (15%) 0.3
35 (15%) 25 (11%) 0.0009
indicates full resolution, the
cutaneous coronary intervention.egreen ofco di
fter
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4
2
2
4
2
2en line
 per
t
s
i
r
i
t
i
fi
r
s
h
s
a
a
t
P
c
r
A
p
f
c
S
d
a
b
a
a
A
h
1
f
C
O
c
p
PSR
V
S
b
†
1768 Sejersten et al. JACC Vol. 54, No. 19, 2009
ST-Segment Resolution and Outcome November 3, 2009:1763–9o reinfarction later. Conversely, in patients without ST-
egment resolution, the microcirculation is disrupted, leav-
ng no or only minor viable myocardium exposed for later
einfarction. The consequence of reinfarction after the index
nfarct is a higher mortality rate (9), making any method
hat can identify patients at increased risk of reinfarction
redictors of Long-Term Outcome in Relation toT-Segment Resolution 4 Hours After St rt ofeperfusion Therapy
Table 4
Pr dictors of L ng-T rm Ou come in Relation to
ST-Segment Resolution 4 Hours After Start of
Reperfusion Therapy
Mortality Reinfarction
All patients
Age 1.08 (1.07–1.10)* 1.03 (1.01–1.04)*
Diabetes mellitus 2.21 (1.48–3.32)* 3.22 (2.00–5.21)*
Heart failure 2.15 (1.59–2.92)* 1.58 (1.07–2.32)†
4-h ST-segment resolution 0.994 (0.990–0.999)* 1.01 (1.00–1.01)
Time to treat 1.16 (0.89–1.50) 0.68 (0.48–0.97)†
pPCI-treated patients
Age 1.08 (1.05–1.10)* 1.02 (0.99–1.05)
Diabetes mellitus 2.40 (1.42–4.04)* 5.37 (2.86–10.08)*
Heart failure 2.63 (1.71–4.04)* 2.16 (1.21–3.86)*
4-h ST-segment resolution 0.997 (0.990–1.004) 0.999 (0.990–1.008)
Time to treat 0.96 (0.61–1.50) 0.69 (0.37–1.29)
Fibrinolysis-treated patients
Age 1.09 (1.07–1.11)* 1.03 (1.01–1.05)*
Diabetes mellitus 1.95 (1.00–3.80)† 1.41 (0.56–3.52)
Heart failure 1.62 (1.04–2.52)† 1.19 (0.70–2.01)
4-h ST-segment resolution 0.992 (0.986–0.998)* 1.011 (1.002–1.020)†
Time to treat 2.25 (1.07–4.73)† 0.45 (0.15–1.39)
alues are hazard ratio (95% confidence interval). Hazard ratio for age is given per 10 years, for
T-segment resolution per absolute change in 1%. Other variables excluded from the model
ecause of insignificant predictive values were clinical variables as listed in Table 1. *p  0.01;
0.01  p  0.05.
pPCI  primary percutaneous coronary intervention.
30-Day and Long-Term Reinfarction According toResolution at 90 Min and 4 Hours After InitiatioTable 5 30-Day and Long-Te m ReinfarctionResolution at 90 Min and 4 Hours A
No Resolution
(<30%)
ST-segment resolution, 90 min
All (n 1,233) 365 (30%)
pPCI (n 602) 129 (21%)
Fibrinolysis (n 631) 236 (37%)
30-day reinfarction
pPCI 3 (2%)
Fibrinolysis 9 (4%)
3-yr reinfarction
pPCI 14 (11%)
Fibrinolysis 21 (9%)
ST-segment resolution, 4 h (%)
All (n 1,208) 248 (21%)
pPCI (n 608) 112 (18%)
Fibrinolysis (n 600) 126 (22%)
30-day reinfarction
pPCI 3 (3%)
Fibrinolysis 6 (4%)
3-yr reinfarction
pPCI 15 (14%)
Fibrinolysis 11 (8%)pPCI  primary percutaneous coronary intervention.mportant. Our results suggest that all patients receiving
brinolysis may benefit from catheterization. Accordingly,
escue PCI in patients with failed fibrinolysis has been
hown not only to reduce reinfarction rates but also to lower
eart failure and mortality (10). Thus, it is tempting to
peculate whether fibrinolysis followed by PCI could be an
lternative to pPCI in areas where pPCI is not ready
vailable. However, caution should be taken regarding both
iming and which fibrinolytic regime to use, as facilitated
CI has been shown to increase stroke rate, ischemic
ardiac complications, heart failure, shock, and mortality
ates (11). On the contrary, the CARESS (Combined
bciximab REteplase Stent Study) trial (12) found im-
roved outcome for STEMI patients immediately trans-
erred for PCI after half-dose reteplase plus abciximab,
ompared to management at the local hospital.
tudy limitations. ST-segment resolution was measured at
ifferent time points after the presumed time of an open
rtery in the 2 treatments groups. This difference could have
iased the findings in favor of pPCI. An ECG immediately
fter PCI may have been preferable and more comparable to
90-min ECG in patients receiving fibrinolytic agents.
dditionally, continuous ST-segment monitoring would
ave been preferable as opposed to the static standard
2-lead ECG because within-patient variability may con-
ound the present observations.
onclusions
ur results indicate that ST-segment resolution in the
onventional 90-min and 4-h ECG remains an important
rognostic factor after fibrinolysis, and confirm the clinical
ree of ST-SegmentR per usion Therapyding to Degre of ST-Segment
Initiation of Reperfusion Therapy
al Resolution
0%–70%)
Complete Resolution
(>70%) p Value
61 (37%) 407 (33%)
33 (39%) 240 (40%)
28 (36%) 167 (27%)
3 (1%) 3 (1%) 0.5
13 (6%) 18 (11%) 0.006
17 (7%) 17 (7%) 0.2
24 (11%) 27 (16%) 0.03
73 (39%) 487 (40%)
46 (41%) 250 (41%)
27 (28%) 237 (40%)
4 (2%) 3 (1%) 0.3
7 (3%) 23 (10%) 0.01
14 (6%) 26 (10%) 0.8
17 (7%) 40 (17%) 0.003Degn ofAcco
fter
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November 3, 2009:1763–9 ST-Segment Resolution and Outcometility of these ECGs in selecting patients for rescue PCI.
he provocative finding of limited prognostic value of
T-segment resolution in a population of STEMI patients
reated with pPCI deserves further investigation, especially
ecause it is already widespread as a surrogate end point in
rials.
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